D. Argun Et Al. , "Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19," Clinical Laboratory , vol.68, no.3, pp.613-621, 2022
Argun, D. Et Al. 2022. Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19. Clinical Laboratory , vol.68, no.3 , 613-621.
Argun, D., Argun, F., BASIM, P., & Bayraktaroglu, M., (2022). Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19. Clinical Laboratory , vol.68, no.3, 613-621.
Argun, Derya Et Al. "Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19," Clinical Laboratory , vol.68, no.3, 613-621, 2022
Argun, Derya Et Al. "Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19." Clinical Laboratory , vol.68, no.3, pp.613-621, 2022
Argun, D. Et Al. (2022) . "Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19." Clinical Laboratory , vol.68, no.3, pp.613-621.
@article{article, author={Derya Argun Et Al. }, title={Monocyte-to-High-Density Lipoprotein Cholesterol Ratio: A Candidate Parameter for a Risk Assessment Model in COVID-19}, journal={Clinical Laboratory}, year=2022, pages={613-621} }